InVitro Moves to Expand Market

InVitro International, which makes products that test toxic levels in substances, said Tuesday that it will broaden its market by licensing a product from another Irvine drug company. InVitro will have the exclusive rights to market a Miragen Inc. product called Guardian DNA that helps to identify any living organism. Miragen will receive exclusive supply rights and future considerations. Financial details were not disclosed.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World
66°